DE60108108D1 - Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren - Google Patents
Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatorenInfo
- Publication number
- DE60108108D1 DE60108108D1 DE60108108T DE60108108T DE60108108D1 DE 60108108 D1 DE60108108 D1 DE 60108108D1 DE 60108108 T DE60108108 T DE 60108108T DE 60108108 T DE60108108 T DE 60108108T DE 60108108 D1 DE60108108 D1 DE 60108108D1
- Authority
- DE
- Germany
- Prior art keywords
- glucocyase
- alkynylphenyl
- heteroaromatic
- activators
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20154600P | 2000-05-03 | 2000-05-03 | |
US201546P | 2000-05-03 | ||
PCT/EP2001/004654 WO2001083465A2 (en) | 2000-05-03 | 2001-04-25 | Alkynyl phenyl heteroaromatic glucokinase activators |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60108108D1 true DE60108108D1 (de) | 2005-02-03 |
DE60108108T2 DE60108108T2 (de) | 2005-12-08 |
Family
ID=22746271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60108108T Expired - Lifetime DE60108108T2 (de) | 2000-05-03 | 2001-04-25 | Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren |
Country Status (18)
Country | Link |
---|---|
US (1) | US6388071B2 (de) |
EP (1) | EP1282612B1 (de) |
JP (1) | JP3788935B2 (de) |
KR (1) | KR100502033B1 (de) |
CN (1) | CN1176915C (de) |
AR (1) | AR032453A1 (de) |
AT (1) | ATE286036T1 (de) |
AU (2) | AU7049401A (de) |
BR (1) | BR0110573A (de) |
CA (1) | CA2407416C (de) |
DE (1) | DE60108108T2 (de) |
EC (1) | ECSP014054A (de) |
ES (1) | ES2233660T3 (de) |
MX (1) | MXPA02010745A (de) |
PE (1) | PE20011310A1 (de) |
PT (1) | PT1282612E (de) |
WO (1) | WO2001083465A2 (de) |
ZA (1) | ZA200208542B (de) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102300D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
EP1336607A1 (de) * | 2002-02-19 | 2003-08-20 | Novo Nordisk A/S | Amidderivate als Glucokinase-Aktivatoren |
US6911545B2 (en) | 2001-12-19 | 2005-06-28 | Hoffman-La Roche Inc. | Crystals of glucokinase and methods of growing them |
GB2409678B (en) * | 2001-12-19 | 2005-09-21 | Hoffmann La Roche | Crystals of glucokinase and methods of growing them and ligands of glucokinase |
WO2003055482A1 (en) | 2001-12-21 | 2003-07-10 | Novo Nordisk A/S | Amide derivatives as gk activators |
RU2340605C2 (ru) | 2002-06-27 | 2008-12-10 | Ново Нордиск А/С | Арилкарбонильные производные в качестве терапевтических средств |
EP1531815B1 (de) | 2002-06-27 | 2014-09-24 | Novo Nordisk A/S | Glukokinase-aktivatoren |
NZ539013A (en) * | 2002-10-03 | 2007-05-31 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
US7132425B2 (en) | 2002-12-12 | 2006-11-07 | Hoffmann-La Roche Inc. | 5-substituted-six-membered heteroaromatic glucokinase activators |
WO2004063179A1 (en) | 2003-01-06 | 2004-07-29 | Eli Lilly And Company | Substituted arylcyclopropylacetamides as glucokinase activators |
PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
PT1723128E (pt) | 2004-01-06 | 2013-02-27 | Novo Nordisk As | Heteroaril-ureias e o seu uso como activadores da glicoquinase |
EP1718625A1 (de) * | 2004-02-18 | 2006-11-08 | AstraZeneca AB | Verbindungen |
WO2005080359A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Benzamide derivatives and their use as glucokinae activating agents |
JP4700684B2 (ja) | 2004-04-02 | 2011-06-15 | ノバルティス アーゲー | 2型糖尿病の処置に有用なグルコキナーゼアクティベーターとしてのスルホンアミド−チアゾロピリジン誘導体 |
CA2561157A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
EP1802570A1 (de) | 2004-10-16 | 2007-07-04 | AstraZeneca AB | Verfahren zur herstellung von phenoxybenzamidverbindungen |
GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
EP1824835A1 (de) | 2004-12-03 | 2007-08-29 | Novo Nordisk A/S | Heteroaromatische glucokinaseaktivatoren |
US20110059941A1 (en) * | 2005-05-24 | 2011-03-10 | Peter William Rodney Caulkett | 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
WO2007006760A1 (en) | 2005-07-08 | 2007-01-18 | Novo Nordisk A/S | Dicycloalkyl urea glucokinase activators |
US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
NZ575514A (en) * | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
WO2007007040A1 (en) * | 2005-07-09 | 2007-01-18 | Astrazeneca Ab | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
EP1910317B1 (de) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | 1-amino-verbundene verbindungen |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
US20090281142A1 (en) | 2005-08-31 | 2009-11-12 | Astellas Pharma Inc. | Thiazole derivative |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−1,2,4−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
CA2626475A1 (en) * | 2005-11-03 | 2007-05-10 | Prosidion Limited | Tricyclo substituted amides |
PT1951658E (pt) | 2005-11-17 | 2012-11-12 | Lilly Co Eli | Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas |
WO2007061923A2 (en) * | 2005-11-18 | 2007-05-31 | Takeda San Diego, Inc. | Glucokinase activators |
TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
JP5302012B2 (ja) | 2006-03-08 | 2013-10-02 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤 |
US8211925B2 (en) | 2006-04-28 | 2012-07-03 | Transtech Pharma, Inc. | Benzamide glucokinase activators |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
WO2007143434A2 (en) | 2006-05-31 | 2007-12-13 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents |
EP2046755A2 (de) | 2006-07-24 | 2009-04-15 | F. Hoffmann-Roche AG | Pyrazole als glucokinase-aktivatoren |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
CL2007003061A1 (es) * | 2006-10-26 | 2008-08-01 | Astrazeneca Ab | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. |
EP2091947A2 (de) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinaseaktivatoren |
BRPI0721143A2 (pt) * | 2006-12-21 | 2014-03-11 | Astrazeneca Ab | Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase |
TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
EP2125735B1 (de) | 2007-02-28 | 2012-06-27 | Advinus Therapeutics Private Limited | 2,2,2-tri-substituierte acetamidderivate als glucokinaseaktivatoren, ihr verfahren und pharmazeutische anwendung |
WO2008111473A1 (ja) * | 2007-03-07 | 2008-09-18 | Kyorin Pharmaceutical Co., Ltd. | グルコキナーゼ活性化物質 |
WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
PE20091313A1 (es) * | 2008-01-15 | 2009-09-03 | Lilly Co Eli | (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina |
RU2010134411A (ru) | 2008-01-18 | 2012-02-27 | Астеллас Фарма Инк. (Jp) | Фенилацетамидное производное |
US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
CA2722733C (en) | 2008-04-28 | 2016-02-23 | Kyorin Pharmaceutical Co., Ltd. | Cyclopentylacrylamide derivative |
EP2324028A2 (de) | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Therapeutische mittel 414 |
UA104742C2 (uk) | 2008-12-19 | 2014-03-11 | Эли Лилли Энд Компани | Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
CN102959076B (zh) | 2010-03-31 | 2015-09-16 | 斯克里普斯研究所 | 重编程细胞 |
US8877754B2 (en) * | 2010-09-06 | 2014-11-04 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
WO2014035872A1 (en) * | 2012-08-27 | 2014-03-06 | Amgen Inc. | Tricyclic alkynes that interact with glucokinase regulatory protein |
EP2878339A1 (de) | 2013-12-02 | 2015-06-03 | Siena Biotech S.p.A. | SIP3-Antagonisten |
EP3053834B1 (de) | 2015-02-04 | 2019-03-27 | Tetra Laval Holdings & Finance S.A. | Anordnung und verfahren zur herstellung mehrerer versiegelter verpackungen für fliessfähige nahrungsmittel aus schlauchförmigem verpackungsmaterial |
CA3093025A1 (en) | 2018-06-12 | 2019-12-19 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61115054A (ja) * | 1984-11-08 | 1986-06-02 | Taisho Pharmaceut Co Ltd | スチレンアルカン酸誘導体 |
EP0831795A2 (de) * | 1995-06-07 | 1998-04-01 | Sugen, Inc. | Phosphatase inhibitoren |
DE69814635T2 (de) * | 1997-06-24 | 2004-03-11 | Zeria Pharmaceutical Co., Ltd. | Verfahren zur herstellung von 2-hydroxybenzamidderivaten |
-
2001
- 2001-04-25 AU AU7049401A patent/AU7049401A/xx active Pending
- 2001-04-25 PT PT01949294T patent/PT1282612E/pt unknown
- 2001-04-25 WO PCT/EP2001/004654 patent/WO2001083465A2/en active IP Right Grant
- 2001-04-25 ES ES01949294T patent/ES2233660T3/es not_active Expired - Lifetime
- 2001-04-25 US US09/841,983 patent/US6388071B2/en not_active Expired - Fee Related
- 2001-04-25 BR BR0110573-6A patent/BR0110573A/pt not_active IP Right Cessation
- 2001-04-25 MX MXPA02010745A patent/MXPA02010745A/es active IP Right Grant
- 2001-04-25 KR KR10-2002-7014725A patent/KR100502033B1/ko not_active IP Right Cessation
- 2001-04-25 JP JP2001580894A patent/JP3788935B2/ja not_active Expired - Fee Related
- 2001-04-25 AU AU2001270494A patent/AU2001270494B2/en not_active Ceased
- 2001-04-25 DE DE60108108T patent/DE60108108T2/de not_active Expired - Lifetime
- 2001-04-25 EP EP01949294A patent/EP1282612B1/de not_active Expired - Lifetime
- 2001-04-25 CA CA002407416A patent/CA2407416C/en not_active Expired - Fee Related
- 2001-04-25 CN CNB018089127A patent/CN1176915C/zh not_active Expired - Fee Related
- 2001-04-25 AT AT01949294T patent/ATE286036T1/de not_active IP Right Cessation
- 2001-04-27 PE PE2001000383A patent/PE20011310A1/es not_active Application Discontinuation
- 2001-04-30 AR ARP010102035A patent/AR032453A1/es not_active Application Discontinuation
- 2001-05-03 EC EC2001004054A patent/ECSP014054A/es unknown
-
2002
- 2002-10-22 ZA ZA200208542A patent/ZA200208542B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200208542B (en) | 2004-01-22 |
MXPA02010745A (es) | 2003-03-10 |
CN1432004A (zh) | 2003-07-23 |
PT1282612E (pt) | 2005-04-29 |
AR032453A1 (es) | 2003-11-12 |
JP3788935B2 (ja) | 2006-06-21 |
KR20020093117A (ko) | 2002-12-12 |
AU2001270494B2 (en) | 2005-11-10 |
JP2003531898A (ja) | 2003-10-28 |
KR100502033B1 (ko) | 2005-07-25 |
PE20011310A1 (es) | 2001-12-31 |
US6388071B2 (en) | 2002-05-14 |
CA2407416C (en) | 2006-07-18 |
ES2233660T3 (es) | 2005-06-16 |
ECSP014054A (es) | 2002-01-25 |
CA2407416A1 (en) | 2001-11-08 |
WO2001083465A3 (en) | 2002-05-16 |
BR0110573A (pt) | 2003-04-01 |
US20010053851A1 (en) | 2001-12-20 |
CN1176915C (zh) | 2004-11-24 |
WO2001083465A2 (en) | 2001-11-08 |
EP1282612A2 (de) | 2003-02-12 |
DE60108108T2 (de) | 2005-12-08 |
AU7049401A (en) | 2001-11-12 |
EP1282612B1 (de) | 2004-12-29 |
ATE286036T1 (de) | 2005-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE286036T1 (de) | Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren | |
DE60134470D1 (de) | Para-amin substituierte phenylamid glukokinase activatoren | |
ATE297921T1 (de) | Tetrazolylphenyl-acetamide als glukokinaseaktivatoren | |
CY2015035I1 (el) | Ενωσεις πυριμιδινης | |
DE60117059D1 (de) | Kondensierte heteroaromatische glucokinaseaktivatoren | |
NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
DE60134094D1 (de) | C7-taxanester als antitumormittel | |
DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
AR027983A1 (es) | Novedosos compuestos | |
NO20025659L (no) | Heterocykliske forbindelser | |
PT1299356E (pt) | Novos compostos | |
IS6732A (is) | Bísýklísk heteróarómatísk efnasambönd | |
AR028220A1 (es) | Novedosos compuestos | |
ATE372338T1 (de) | Deshalogenverbindungen | |
NO20031837L (no) | Kalsilytiske forbindelser | |
NO20030303L (no) | Kalsilytiske forbindelser | |
NO20023508L (no) | Kalsilyttiske forbindelser | |
AR028399A1 (es) | Nuevos compuestos | |
SE0003436D0 (sv) | Novel compounds | |
SE0002331D0 (sv) | Novel compounds | |
SE0004824D0 (sv) | Novel compounds | |
SE0004611D0 (sv) | Novel Compounds | |
SE0002234D0 (sv) | Novel compounds | |
SE0003203D0 (sv) | Novel compounds | |
SE0003979D0 (sv) | Novel Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |